Miharu Masuoka

Suggest Changes
Learn More
BACKGROUND The ultra-short-acting beta1-selective blocker, landiolol, is widely used in Japan. We investigated the effects of landiolol on intubation-induced adrenergic response in 88 patients. (More)
  • 1